Selected article for: "cancer patient and novel coronavirus"
Author: Al-Quteimat, Osama M.; Amer, Amer Mustafa
Title: The Impact of the COVID-19 Pandemic on Cancer Patients
  • Cord-id: l39na6s8
  • Document date: 2020_4_23
    • ID: l39na6s8
    Snippet: In December 2019, a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused an outbreak of coronavirus disease 2019 (COVID-19). Severe complications have been reported to occur in 33% of patients with COVID-19 and include acute respiratory distress syndrome, acute renal failure, acute respiratory injury, septic shock, and severe pneumonia. Currently, there is no specific treatment or approved vaccine against COVID-19 and many clinical trials are currently inv
    Document: In December 2019, a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused an outbreak of coronavirus disease 2019 (COVID-19). Severe complications have been reported to occur in 33% of patients with COVID-19 and include acute respiratory distress syndrome, acute renal failure, acute respiratory injury, septic shock, and severe pneumonia. Currently, there is no specific treatment or approved vaccine against COVID-19 and many clinical trials are currently investigating potential medications to treat COVID-19. The immunosuppressed status of some cancer patients (whether caused by the disease itself or the treatment) increases their risk of infection compared with the general population. This short review aims to focus on the impact of COVID-19 on a cancer patient and discuss management options and recommendation in addition to highlighting the currently available clinical guidelines and resources.

    Search related documents:
    Co phrase search for related documents
    • acceptable safety and acute respiratory distress syndrome: 1
    • acceptable safety and lopinavir ritonavir: 1, 2
    • acceptable safety and lung cancer: 1, 2
    • acute leukemia and lopinavir ritonavir: 1, 2
    • acute leukemia and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8
    • acute myocardial infarction and lopinavir ritonavir: 1
    • acute renal failure and lopinavir ritonavir: 1, 2, 3, 4, 5
    • acute renal failure and lung cancer: 1
    • acute renal failure and lung cancer patient: 1
    • acute respiratory distress syndrome and administer dose: 1
    • acute respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and lung cancer patient: 1
    • acute respiratory injury and lopinavir ritonavir: 1, 2, 3, 4
    • acute respiratory injury and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • lopinavir ritonavir and lung cancer: 1, 2, 3
    • lopinavir ritonavir and lung cancer patient: 1, 2